Top compounds associated with response to AL109923.1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	tivantinib	CTRPv2	pan-cancer	AAC	-0.097	0.04
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.07	0.04
mRNA	vincristine	CTRPv2	pan-cancer	AAC	-0.063	0.04
mRNA	CID-5951923	CTRPv2	pan-cancer	AAC	-0.078	0.04
mRNA	AZD0530	CTRPv2	pan-cancer	AAC	0.075	0.04
mRNA	KHS101	CTRPv2	pan-cancer	AAC	-0.075	0.05
mRNA	Ki8751	CTRPv2	pan-cancer	AAC	-0.072	0.05
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.075	0.05
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.07	0.05
mRNA	betulinic acid	CTRPv2	pan-cancer	AAC	-0.076	0.05

Download CSV